EphA3 antibodies for the treatment of multiple myeloma

Details for Australian Patent Application No. 2011235867 (hide)

Owner KaloBios Pharmaceuticals, Inc.

Inventors Palath, Varghese; Bebbington, Christopher R.

Agent Pizzeys

Pub. Number AU-A-2011235867

PCT Pub. Number WO2011/123819

Priority 61/320,230 01.04.10 US

Filing date 1 April 2011

Wipo publication date 6 October 2011

International Classifications

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

C12Q 1/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/123819 Priority application(s): WO2011/123819

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235868-Single isomeric conjugates of rhodamine dyes

2011235863-Methods of improving quality of sleep